Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"Tipifarnib"”.

  1. Etablierung eines 3D in vitro Blutgefäß-/Gewebemodells zur Testung spezifischer Therapeutika zur Leukämiebehandlung

    … THP-1 Zellen (AML-M5-Zelllinie) und Tipifarnib oder entsprechende Kontrolllösungen beziehungsweise bimolekulare Antikörperkonstrukte mit PBMCs als Effektorzellen hinzupipettiert. Nach 5-tägiger Inkubation mit Tipifarnib beziehungsweise 24-stündiger Behandlung mit …

    wurz-thes Repository record for Etablierung eines 3D in vitro Blutgefäß-/Gewebemodells zur Testung spezifischer Therapeutika zur Leukämiebehandlung (opens in a new tab)

  2. Synergy and Resistance Mechanisms in R115777 and PS-341 Models of Myeloma and Leukemia

    … transferase inhibitor R115777 (Zarnestra, Tipifarnib) has been found to have clinical activity in diverse hematopoietic tumors. Clinical efficacy, however, does not correlate with Ras mutation status or inhibition of farnesyl transferase. To further elucidate the mechanisms by which R115777 …

    usf Repository record for Synergy and Resistance Mechanisms in R115777 and PS-341 Models of Myeloma and Leukemia (opens in a new tab)

  3. Developing Novel Antifungal Compounds for Use as Single-Agent and in Multi-Drug Combination Therapies for Treating Invasive Fungal Infections

    … Administration (FDA) approved carcinoma product Tipifarnib are assessed for their in vitro antifungal activity through microdilution broth minimum inhibitory concentration (MIC) assays. The mechanism of action of Tipifarnib was visualized using fluorescence microscopy before resistance mechanisms …

    duke Repository record for Developing Novel Antifungal Compounds for Use as Single-Agent and in Multi-Drug Combination Therapies for Treating Invasive Fungal Infections (opens in a new tab)

  4. TARGETING FARNESYLATION AS A NOVEL THERAPEUTIC APPROACH IN HRAS-MUTANT RHABDOMYOSARCOMA

    … novel RMS preclinical models and utilized tipifarnib, a potent and selective FTase inhibitor, in in vitro and in vivo models of RMS genomically characterized for RAS mutation status. FTase inhibition reduced HRAS processing, and plasma membrane localization leading to decreased GTP-bound …

    jhu Repository record for TARGETING FARNESYLATION AS A NOVEL THERAPEUTIC APPROACH IN HRAS-MUTANT RHABDOMYOSARCOMA (opens in a new tab)

  5. Zelluläre Seneszenz induziert durch neue zielgerichtete Therapien

    … Ibrutinib, Idelalisib, Imatinib, Palbociclib, Tipifarnib und Vemurafenib) oder mit dem konventionellen Chemotherapeutikum Adriamycin behandelt und hinsichtlich ihres Wachstumsverhaltens sowie ihrer Viabilität untersucht. Am sechsten Tag nach Behandlung erfolgten die histochemische und …

    fu-berlin Repository record for Zelluläre Seneszenz induziert durch neue zielgerichtete Therapien (opens in a new tab)

  6. Effect of Sympathetic Nervous System Mediators On The Tumor Microenvironment Via Small Extracellular Vesicles In Ovarian Cancer

    … exposed to control and stress-conditioned EVs. Tipifarnib, a farnesyl transferase inhibitor, was used to inhibit small EV secretion to study dependence of outcomes of previously performed functional assays on EV number. Mass spectrometry (MS) was performed on control and stress-conditioned small …

    uthsc Repository record for Effect of Sympathetic Nervous System Mediators On The Tumor Microenvironment Via Small Extracellular Vesicles In Ovarian Cancer (opens in a new tab)

  7. Structure-Guided Development of Antifungal Protein Farnesyltransferase Inhibitors and DNA Polymerase Engineering

    … and evaluated another human FTase inhibitor Tipifarnib. The derivatives showed the improved antifungal activity against Cryptococcus neoformans and Candida albicans. Finally, we have developed a new system to produce Plasmodium falciparum FTase for future inhibitor development. The data …

    duke Repository record for Structure-Guided Development of Antifungal Protein Farnesyltransferase Inhibitors and DNA Polymerase Engineering (opens in a new tab)